2025 - 10 - 01

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

2020 - 08 - 20

Ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR® POC instrument

2020 - 07 - 16

Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay

2020 - 04 - 02

Credo Diagnostics Biomedical And A. Menarini Diagnostics Sign An Exclusive Distribution Agreement For Sars-cov-2 Assay On The Vitapcrtm Platform

2020 - 02 - 19

ATTD 2020

2020 - 02 - 03

MEDLAB Middle East